Ranbaxy (Malaysia) Sdn. Bhd. is a Malaysia-based pharmaceutical company historically engaged in the marketing and distribution of generic pharmaceutical products. The company's operations included regulatory coordination, product registration, supply chain management, and commercial distribution of medicines to hospitals, clinics, pharmacies, and healthcare institutions. Its product portfolio typically encompassed a range of prescription and over-the-counter pharmaceutical formulations addressing therapeutic areas such as anti-infectives, cardiovascular, and chronic disease management. Operating within Malaysia's regulated pharmaceutical environment, the company adhered to stringent quality, safety, and compliance standards. Strategically, Ranbaxy (Malaysia) was positioned to expand access to affordable generic medicines, focusing on product availability, regulatory compliance, and healthcare provider engagement within Malaysia's pharmaceutical market.
Headquarters
Unit 21-13, Level 21, Q Sentral, 2A Jalan Stesen Sentral 2, Kuala Lumpur Sentral
Kuala Lumpur; Federal Territories;
Postal Code: 50470
Contact Details: Purchase the Ranbaxy (Malaysia) Sdn. Bhd. report to view the information.
Website: http://www.sunpharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service